About BioTeZ
BioTeZ is a Healthcare company based in Berlin (Germany) founded in 1992, and was acquired by BBI Solutions in January 2022. Life science products and services are offered by BioTeZ. The company has 20 employees. Its chief executive, as recorded, is Uwe Ahnert. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Diversified. Its legal entity is BioTeZ Berlin-Buch GmbH Biochemisch-Technologisches Zentrum.
Company details
BioTeZ was founded in 1992 and is based in Berlin, Germany. Operations are centered in the life sciences sector, where products and services such as DNARNA oligonucleotide development, immunoaffinity columns and gels, ELISA and other assays, labeling kits and services, microplate coating, streptavidin tools, antibodies, proteins, enzymes, and related items are provided to support biotechnology research and applications.
- Headquarters Berlin, Germany
- Employees 20
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biotez.de
- Social LinkedIn X
- Acquired by BBI Solutions (Jan 2022)
- Legal Name Biotez Berlin-Buch Gmbh Biochemisch-Technologisches Zentrum
- Investors
- Employee Count20
- Acquired byBBI Solutions
(Jan 2022)
Investors in BioTeZ
BioTeZ has secured backing from 1 investor. Prominent investors backing the company include BBI Solutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Kits and reagents are developed for life science research applications. | 1986 | bbisolutions.com | Crumlin, United Kingdom |
Investor details for BioTeZ
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BioTeZ
1 people are tracked at BioTeZ (1 in leadership); the tracked headcount is 20.
| Name | Role | Group |
|---|---|---|
Uwe Ahnert | CEO & Managing Director | Leadership |
Complete people profiles for BioTeZ
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BioTeZ
2 dated milestones of BioTeZ across 30 years, from founding to its latest funding, stage changes and deals.
- Founded BioTeZ is founded.
- Exit Acquired by BBI Solutions.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioTeZ
BioTeZ was founded in 1992.
BioTeZ is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Uwe Ahnert is the CEO of BioTeZ, as recorded in our data.
BioTeZ has 20 employees.
BioTeZ was founded in 1992 and is based in Berlin, Germany. Operations are centered in the life sciences sector, where products and services such as DNARNA oligonucleotide development, immunoaffinity columns and gels, ELISA and other assays, labeling kits and services, microplate coating, streptavidin tools, antibodies, proteins, enzymes, and related items are provided to support biotechnology research and applications.
BioTeZ has 1 investor. Key investors include BBI Solutions.
BioTeZ operates through Biotez Berlin-Buch Gmbh Biochemisch-Technologisches Zentrum.
Yes. BioTeZ was acquired by BBI Solutions in January 2022.